EmStop has announced the start of the CAPTURE-2 Investigational Device Exemption (IDE) clinical trial for its investigational embolic protection system designed for Transcatheter Aortic Valve Replacement

Cancer Check Labs has entered into a strategic partnership with Evexia Diagnostics to expand access to early cancer detection testing through the CancerCheck multi-cancer early detection (MCED) test.

Cepheid, a company of Danaher, has received CE marking under the In Vitro Diagnostic Regulation (IVDR) for its Xpert® GI Panel. The multiplex PCR test is designed to rapidly detect 11 gastrointestinal pathogens from a single patient sample.

Philips secures spot on Financial Times' top 3 medtech employers in Asia for 2026, backed by robust full-year 2025 sales of $20.62 billion and rising order intake in key hospital technologies.

Sincere Healthcare Group and Landmark Medical Centre have mutually agreed to terminate their partnership, ensuring continuity of operations in Johor Bahru.

Jindal Healthcare rebrands to Anka, introducing an AI-native platform that automates revenue recovery and protects hospitals from escalating payer denials.

Stryker signs definitive agreement to acquire Amplitude Vascular Systems, enhancing its cardiology portfolio with next-generation intravascular lithotripsy technology for Asian hospital networks.

Global investment firm Carlyle has acquired majority stakes in two leading US healthcare revenue cycle management firms, enhancing operational efficiency for hospitals nationwide.

GE HealthCare announces FDA approval for its latest AI-enhanced ultrasound platform, revolutionizing real-time patient monitoring in American hospital critical care units.

Philips earns a spot among the Financial Times' top 3 medtech companies to work for in Asia in 2026, highlighting its diagnostic imaging systems and patient monitoring technologies for hospitals.[2]